New hope for liver-spread pancreatic cancer: targeted chemo combo shows promise
NCT ID NCT06538623
First seen Mar 26, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tested a new treatment for people with pancreatic cancer that spread only to the liver, after their first chemotherapy stopped working. The treatment delivers two chemotherapy drugs directly to the liver through a thin tube, followed by more chemo either through the tube or as pills. The goal was to see if this approach could help control the disease and improve survival. 40 adults took part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 2000010, China
Conditions
Explore the condition pages connected to this study.